美国癌症协会发布前列腺癌患者生存指南

链接地址：http://www.biodiscover.com/news/research/110426.html 近日，美国癌症协会（ACS）首次向前列腺癌症患者和医生公布了前列腺癌症患者的生存指南，主要涵盖了五大方面的内容。

                               
登录/注册后可看大图

David Samadi

6月，美国癌症协会（ACS）首次向前列腺癌症患者和医生公布了前列腺癌症患者的生存指南。
尽管随着高度有效的治疗方案、智能前列腺手术、辐射技术以及激素疗法的进步， 前列腺癌复苏的概率大大提升。
但是目前为止，由于信息的不对称，前列腺癌症患者在术后的生活和后续治疗难以控制自己处于长期康复状态。
作为纽约前列腺外科手术医生、医学博士David Samadi强调后处理协议对所有病人的重要性。
他说，“我很高兴地看到美国癌症协会（ACS）关注前列腺癌症患者术后的生活，即使手术的成功，病人需要监视身心恢复过程和长期警惕癌症复发。”
指南分为五个主要类别：
健康促进
做好肥胖、体力活动、戒烟、限制饮酒等方面咨询营养。
前列腺癌的监测
建议定期做好前列腺特异抗原（PSA）数字直肠检查（DREs）检查。
二次癌症意识
监测症状副作用细节，二次癌症的早期检测，尤其是接受了放射治疗的患者。
身体和心理管理
身体管理：患者术后尿液、肠道及性功能的监测与管理；
心理管理：前列腺癌对情感和心理潜在的副作用影响；
另外，还包括监测心血管、代谢和骨骼健康。
护理协调
建议将前列腺癌患者的术后护理转向培养专业的初级护理协调员，同时加强临床医生、市场护理及家庭成员的合作。
Samadi博士补充说：“新准则将成为病人教育过程中一个有价值的工具，患者知道治疗前后的内容越多，他们作出健康积极的决定的可能性越大。”




参考文献
我要补充文献

                               
登录/注册后可看大图

American Cancer Society prostate cancer survivorship care guidelines                                             文献检索：DOI: 10.3322/caac.21234                                                         

Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow-up care to address the myriad of long-term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow-up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long-term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility-specific and population databases.

展开

感谢分享，楼主快我一些

xiaoxiao 发表于 2014-6-23 12:55 PM
感谢分享，楼主快我一些

呵呵。我是来的早的时候就弄弄